For the quarter ending 2026-03-29, ILMN had -$329M decrease in cash & cash equivalents over the period. $251M in free cash flow.
| Cash Flow | 2026-03-29 | 2025-12-28 | 2025-09-28 | 2025-06-29 |
|---|---|---|---|---|
| Revenue-Core Illumina | - | 1,159 | 1,084 | 1,059 |
| Cost of revenue-Core Illumina | - | 400 | 351 | 364 |
| Research and development-Core Illumina | - | 239 | 229 | 247 |
| Selling and marketing-Core Illumina | - | 160 | 147 | 146 |
| General and administrative-Core Illumina | - | 149 | 129 | 88 |
| Goodwill and intangible impairment-Core Illumina | - | 0 | 0 | 0 |
| Legal contingency and settlement-Core Illumina | - | -10 | 0 | - |
| Revenue-GRAILInc. | - | 0 | 0 | 0 |
| Total operating expenses-GRAILInc. | - | 0 | 0 | 0 |
| Consolidated other income (expense), net-GRAILInc. | - | -176 | 7 | -92 |
| Consolidated provision for income taxes-GRAILInc. | - | 43 | 71 | 71 |
| Net income | 134 | 334 | 150 | 235 |
| Depreciation expense | 51 | 50 | 50 | 51 |
| Amortization of intangible assets | 18 | 16 | 17 | 17 |
| Share-based compensation expense | 60 | 63 | 70 | 69 |
| Deferred income taxes | 3 | -37 | -41 | -25 |
| Net losses (gains) on strategic investments | -38 | 191 | 4 | 101 |
| Change in fair value of contingent consideration liabilities | -16 | 11 | 3 | -21 |
| Goodwill and intangible impairment | - | 0 | 0 | 23 |
| Property and equipment and right-of-use asset impairment | - | 0 | 4 | 0 |
| Non-cash charitable contribution | - | 19 | - | - |
| Gain on helix contingent value right | - | 0 | 0 | 0 |
| Other | -8 | 0 | -9 | -11 |
| Accounts receivable | -118 | 121 | 36 | -3 |
| Inventory | 13 | -26 | 15 | 38 |
| Prepaid expenses and other current assets | 2 | 7 | 12 | -5 |
| Operating lease right-of-use assets and liabilities, net | 9 | 9 | 8 | 9 |
| Other assets | 26 | 8 | 10 | 2 |
| Accounts payable | -12 | 15 | 13 | -11 |
| Accrued liabilities | -47 | 69 | 22 | -35 |
| Other long-term liabilities | -10 | 17 | -10 | 12 |
| Net cash provided by operating activities | 289 | 321 | 284 | 234 |
| Net purchases of property and equipment | 38 | 55 | 31 | 30 |
| Net sales (purchases) of strategic investments | -87 | -166 | 20 | 19 |
| Cash paid for acquisitions and intangible assets, net of cash acquired | 415 | 3 | 0 | 0 |
| Cash received for helix contingent value right | - | 0 | 0 | - |
| Net cash used in investing activities | -366 | 108 | -51 | -49 |
| Common stock repurchases | 242 | 42 | 130 | 370 |
| Taxes paid related to net share settlement of equity awards | 33 | 16 | 1 | 1 |
| Proceeds from issuance of common stock | 24 | 0 | 16 | 1 |
| Payments on contingent consideration liabilities | - | 0 | 0 | 1 |
| Proceeds from debt, net of issuance costs | - | 495 | 0 | - |
| Payments on debt obligations | - | 500 | 0 | - |
| Grail cash deconsolidated as a result of spin-off | - | 0 | 0 | 0 |
| Borrowings on delayed draw term loan, net of issuance costs | - | - | - | -744 |
| Net cash used in financing activities | -251 | -63 | -115 | -371 |
| Effect of exchange rate changes on cash and cash equivalents | -1 | 2 | -2 | 7 |
| Net decrease in cash and cash equivalents | -329 | 368 | 116 | -179 |
| Cash and cash equivalents at beginning of period | 1,418 | 1,050 | 934 | 1,113 |
| Cash and cash equivalents at end of period | 1,089 | 1,418 | 1,050 | 934 |
ILLUMINA, INC. (ILMN)
ILLUMINA, INC. (ILMN)